SCHEMBL5772189

SCHEMBL5772189

CC1(C)c2ccc(CCN3CCN(c4onc5ccccc45)CC3)cc2C(C)(C)C1NC(=O)COS(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 17/20 0.36
KCNH2 Q12809 16/20 0.36
HTR2A P28223 15/20 0.36
DRD2 P14416 15/20 0.36
HTR1D P28221 2/20 0.35
HTR1B P28222 2/20 0.35
DRD3 P35462 2/20 0.35
HTR2C P28335 1/20 0.35
HTR7 P34969 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772179 0.88 HTR1A (0.42) HTR1AKCNH2HTR2ADRD2HTR1D
SCHEMBL6407024 0.87 HTR2A (0.42) HTR1AHTR2ADRD2HTR7
SCHEMBL5738687 0.85 HTR1A (0.41) HTR1AKCNH2HTR2ADRD2HTR1D
SCHEMBL5750335 0.79 HTR1A (0.39) HTR1AKCNH2HTR2ADRD2HTR1D
SCHEMBL5738682 0.76 SIGMAR1 (0.38) HTR1AHTR2ADRD2HTR1DHTR1B
SCHEMBL6407019 0.75 HTR2A (0.46) HTR1AKCNH2HTR2ADRD2HTR7
SCHEMBL5740933 0.74 HTR2A (0.38) HTR1AKCNH2HTR2ADRD2HTR1D
SCHEMBL6400717 0.73 HTR2A (0.48) HTR1AKCNH2HTR2ADRD2HTR7
SCHEMBL6401393 0.72 HTR2A (0.47) HTR1AHTR2ADRD2HTR7
SCHEMBL6404382 0.71 HTR2A (0.46) HTR1AHTR2ADRD2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697334-A1 HETEROCYCLIC SUBSTITUTED INDANE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA Warner-Lambert Company LLC (US) 2006-09-06 EP disclosed
WO-2005056540-A1 HETEROCYCLIC SUBSTITUTED INDANE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2005-06-23 WO disclosed